Search research articles
Contact Us
Filters
Showing results (411-420 of 518) with videos related to
Page
of 52
Sort By:
The Milbank Quarterly
|
March 7, 2014
What can health communication science offer for ACA implementation? Five evidence-informed strategies for expanding Medicaid enrollment
Matthew W Kreuter, Timothy D McBride, Charlene A Caburnay, et al.
Infectious Disorders Drug Targets
|
September 4, 2024
Host Risk Factors for Tuberculosis
Vahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Mohammad Asgharzadeh, et al.
Veterinary Journal (London, England : 1997)
|
February 6, 2026
Soluble and insoluble fiber blend improves farrowing performance and colostral immunoglobulin concentration in sows without altering fecal microbiota
Bruno Bracco Donatelli Muro, Rafaella Fernandes Carnevale, Matheus Saliba Monteiro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 5, 2014
Molecular mechanism and structure of the Saccharomyces cerevisiae iron regulator Aft2
Catherine B Poor, Seraphine V Wegner, Haoran Li, et al.
BMJ Open Respiratory Research
|
September 3, 2025
Transpulmonary bubble transit in patients hospitalised with COVID-19 pneumonia
Hooman Poor, Adeel Abassi, Daniel Howell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 14, 2014
Probing the paramyxovirus fusion (F) protein-refolding event from pre- to postfusion by oxidative footprinting
Taylor A Poor, Lisa M Jones, Amika Sood, et al.
Transplantation Proceedings
|
May 26, 2007
Iranian model of renal allograft transplantation in 3028 recipients: survival and risk factors
B Einollahi, V Pourfarziani, M Ahmadzad-Asl, et al.
British Journal of Haematology
|
June 13, 2002
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma
Jonathan W Friedberg, Donna Neuberg, John G Gribben, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets
|
March 10, 2020
Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran
Mohammad Asgharzadeh, Zahra A Jigheh, Hossein S Kafil, et al.
Scientific Reports
|
December 19, 2022
Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report
Davide Garzone, Jan Henrik Terheyden, Olivier Morelle, et al.
Page
of 52
Search research articles
Search
Showing results (411-420 of 518) with videos related to
Sort By:
Page
of 52
The Milbank Quarterly
|
March 7, 2014
What can health communication science offer for ACA implementation? Five evidence-informed strategies for expanding Medicaid enrollment
Matthew W Kreuter, Timothy D McBride, Charlene A Caburnay, et al.
Infectious Disorders Drug Targets
|
September 4, 2024
Host Risk Factors for Tuberculosis
Vahid Asgharzadeh, Seyyed Amin Seyyed Rezaei, Mohammad Asgharzadeh, et al.
Veterinary Journal (London, England : 1997)
|
February 6, 2026
Soluble and insoluble fiber blend improves farrowing performance and colostral immunoglobulin concentration in sows without altering fecal microbiota
Bruno Bracco Donatelli Muro, Rafaella Fernandes Carnevale, Matheus Saliba Monteiro, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 5, 2014
Molecular mechanism and structure of the Saccharomyces cerevisiae iron regulator Aft2
Catherine B Poor, Seraphine V Wegner, Haoran Li, et al.
BMJ Open Respiratory Research
|
September 3, 2025
Transpulmonary bubble transit in patients hospitalised with COVID-19 pneumonia
Hooman Poor, Adeel Abassi, Daniel Howell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 14, 2014
Probing the paramyxovirus fusion (F) protein-refolding event from pre- to postfusion by oxidative footprinting
Taylor A Poor, Lisa M Jones, Amika Sood, et al.
Transplantation Proceedings
|
May 26, 2007
Iranian model of renal allograft transplantation in 3028 recipients: survival and risk factors
B Einollahi, V Pourfarziani, M Ahmadzad-Asl, et al.
British Journal of Haematology
|
June 13, 2002
Combination immunotherapy with rituximab and interleukin 2 in patients with relapsed or refractory follicular non-Hodgkin's lymphoma
Jonathan W Friedberg, Donna Neuberg, John G Gribben, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets
|
March 10, 2020
Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran
Mohammad Asgharzadeh, Zahra A Jigheh, Hossein S Kafil, et al.
Scientific Reports
|
December 19, 2022
Comparability of automated drusen volume measurements in age-related macular degeneration: a MACUSTAR study report
Davide Garzone, Jan Henrik Terheyden, Olivier Morelle, et al.
Page
of 52